Want to join the conversation?
Drug and medical devices maker $MNK completes the acquisition of Therakos, Inc. for value of approx. $1.325Bil. $MNK expects FY15 net sales of $185-$195MM for Therakos products & high single-digit growth going forward. The transaction is accretive $0.10 per share to $MNK's adjusted diluted FY16 earnings & increasingly accretive thereafter.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.